A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair for—left ventricular non-compaction, also known as spongy heart disease. The new therapeutic approach, performed in utero, may prevent babies from being born with this life-threatening disease, which often causes the dire need for a heart transplant.
This article was originally published on MedicalXpress.com

